In the Samara Region, the First Regional Nuclear Medical Center Has Opened

30 November 2017

In Togliatti, the grand opening of the ninth Positron Emission Tomography Center by the RUSNANO portfolio company PET-Technology has been held. The opening ceremony was attended by the Interim Goveneror of the Samara Region Dmitry Azarov, RUSNANO Deputy Board Chairman Vladimir Avetisyan, and PET-Technology General Director Diana Kobesova. The extent of investments in the construction and equipping of the medical center amounted to 208 million rubles.

The diagnostic center is located at the Togliatti #5 City Clinical Hospital and is equipped with a modern GE Discovery 610 PET/CT scanner, with the capacity of 3-4 people per hour or 6 thousand people per year. By the end of this year, 420 PET/CT examinations are planned and about 5,000 diagnostic procedures in 2018.

The Togliatti PET Center will become part of the diagnostic hub as a new model for organizing the production of radiopharmacueticals and of several diagnostic centers surrounding it. Radiopharamaceuticals required for PET/CT diagnostics will be delivered to the PET center in Togliatti from its own production center, PET-Technology, located in Ufa. Delivery will be carried out by special automobile and air transport.

“One of the main goals of building PET centers is to increase the availability of cutting edge medicine in the region. In this area, active cooperation with state authorities is underway: residents of the Samara Region can undergo diagnostic examinations free of charge within the framework of the state OMS (compulsory health insurance) system,” said Diana Kobesova, CEO of PET-Technology. “The method for examination, which is used at the center, allows for the quick determination of the extent of malignant processes in the human body. The results of the PET/CT examination enable the treating physician to plan the patient's treatment and monitor its effectiveness.”

For the purpose of continuing the medical education of doctors, it is planned to create various joint programs with medical institutions in the Samara Region. Employees of PET-Technology have an extensive network of professional contacts with leading centers in Europe and the USA, as well as possess the skills to conduct educational and scientific events.

“Our main goal is to ensure that as many people as possible have the opportunity to be healthy. All this depends on diagnosis at an early stage and proper treatment planning. The center, which is open today, will help people to have the opportunity to receive such assistance,” said Dmitry Azarov, the Interim Governor of the Samara Region.

In March 2018, another regional PET Center will be opened in the capital of the region, Samara, which will specialize not only in the diagnosis of cancer, but also in cardiological research: PET/CT diagnostics can be used to diagnose early stages of coronary heart disease, to study old heart attacks, assess shunting and its consequences. This will be the first center in Russia to apply PET/CT to cardiology in terms of practical radiology.

“The Samara Region in 2018 will be the only region in Russia where two PET centers will operate at once. Local authorities understand the social importance of this project and are contributing in every way to its implementation. RUSNANO is expanding the federal network of nuclear medicines centers every year. Today more than 53,000 patients have been examined in them with the overwhelming majority free of charge under OMS policy,” said RUSNANO Deputy Board Chairman Vladimir Avetisyan.

Additional information

Reference

RUSNANO Joint-Stock Company was founded in March 2011 through reorganization of state corporation Russian Corporation of Nanotechnologies. JSC RUSNANO contributes to implementation of the state policy on the development of the nanotechnology industry by investing directly and through investment funds of nanotechnology in financially effective high-technology projects providing the development of new production facilities in the Russian Federation. Its primary investment focus is in electronics, optoelectronics and telecommunications, healthcare and biotechnology, metallurgy and metalwork, energy, mechanical engineering and instrument making, construction and industrial materials, chemicals and petrochemicals. 100 percent of RUSNANO’s shares are state owned. Thanks to RUSNANO’s investments, there are currently 87 factories and R&D Centers opened in 32 regions in Russia.

Management of assets of RUSNANO JSC is carried out by Limited Liability Company established in December 2013, RUSNANO Management Company. Anatoly Chubais is the Chairman of its Executive Board.

Work to establish nanotechnology infrastructure and carry out educational programs is fulfilled by RUSNANO’s Fund for Infrastructure and Educational Programs, which was also established during the reorganization of the Russian Corporation of Nanotechnologies.

* * *

PET-Technology LLC, RUSNANO’s Portfolio Company, was founded in 2011 in order to implement the project “Establishment of a network of regional PET/CT Centers for diagnostic procedures”—Nuclear Medicine Centers.

The Federal Network of Nuclear Medicine Centers will provide the Russian people with the access to advanced technology for the high-quality diagnostics and treatment of oncology diseases.

The first of the Federal Network of Modern Medical Centers that was established within a public-private partnership, was the Nuclear Medicine Center in Ufa. It provides a range of services for the diagnostics of oncology diseases using the PET/CT and for the treatment of tumours using the latest robotized CyberKnife radio surgery system. The accuracy, effectiveness and safety of the CyberKnife allows us to treat brain tumours that surgery and usual radiotherapy cannot help.

The PET-Technology produces radiopharmaceuticals necessary for PET/CT diagnostics at its production facilities in Ufa and Yelets (in the Lipetsk Region), which are equipped with a cyclotron complex, radiopharmaceuticals synthesis laboratory, equipment for dosing and packaging radiopharmaceuticals, as well as with quality control devices.

The regional divisions of the PET-Technology network provide PET/CT diagnostic services in areas of medical specialists to patients free of charge at the expense of the compulsory health insurance funds, and on a paid basis.